Tokyo, Japan

Takeshi Shida

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovations of Takeshi Shida

Introduction

Takeshi Shida is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in developing therapeutic agents for gastrointestinal disorders. With a total of 3 patents to his name, Shida's work is recognized for its innovative approach and high safety standards.

Latest Patents

One of Shida's latest patents is focused on piperazinyl cyclohexane compounds as GPR38 agonists. This invention aims to find a therapeutic and/or prophylactic agent for gastrointestinal disorders, showcasing excellent activity and high safety. The compound is represented by a specific general formula, which includes various substituents and functional groups that enhance its pharmacological properties. Another notable patent is the piperazinyl methyl phenyl cyclohexane compound, which shares similar objectives and characteristics, further emphasizing Shida's commitment to advancing medical treatments.

Career Highlights

Takeshi Shida is currently associated with Daiichi Sankyo Company, Limited, a leading pharmaceutical company known for its innovative research and development. His work at Daiichi Sankyo has allowed him to collaborate with other talented professionals in the field, contributing to the advancement of therapeutic solutions.

Collaborations

Shida has worked alongside notable colleagues such as Narihiro Toda and Rieko Takano. Their collaborative efforts have played a crucial role in the development of innovative compounds aimed at improving patient outcomes.

Conclusion

Takeshi Shida's contributions to the field of pharmaceuticals are noteworthy, particularly in the development of compounds for gastrointestinal disorders. His innovative patents and collaborations reflect his dedication to enhancing medical treatments and improving patient safety.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…